Published in Clin Diagn Lab Immunol on January 01, 1998
Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry. Clin Diagn Lab Immunol (2000) 0.85
Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. PLoS One (2013) 0.81
Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients. J Clin Microbiol (2000) 0.75
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62
Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature (1978) 9.25
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE. J Clin Pathol (1965) 8.64
Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science (1970) 7.60
Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell (1988) 5.76
Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol (1972) 4.66
Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst (1966) 4.19
DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell (1980) 4.14
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol (1987) 4.12
Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology (1979) 4.02
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes). Proc Natl Acad Sci U S A (1972) 3.89
Analysis of cell populations with a fluorescence-activated cell sorter. Ann N Y Acad Sci (1975) 3.76
Epstein-Barr virus with heterogeneous DNA disrupts latency. J Virol (1984) 3.51
Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer (1984) 3.49
Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol (1990) 3.09
Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J Virol (1983) 3.06
Activation of latent Epstein-Barr virus by antibody to human IgM. Nature (1978) 2.33
Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. J Virol (1979) 2.31
Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. Virology (1979) 2.09
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
Complexity of EBV homologous DNA in continous lymphoblastoid cell lines. Virology (1976) 1.99
Sequence analysis of Raji Epstein-Barr virus DNA. Virology (1988) 1.95
Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology (1984) 1.85
Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology (1990) 1.78
Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Proc Natl Acad Sci U S A (1971) 1.78
TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology (1988) 1.56
Mononucleosis with heterophil antibodies and EB virus infection. Acquisition by an elderly patient in hospital. Am J Med (1971) 1.41
Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology (1987) 1.35
Characterization of proteins encoded by the Epstein-Barr virus transactivator gene BMLF1. Virology (1989) 1.21
The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. J Virol (1995) 1.18
Epstein-Barr virus SM protein. Virology (1994) 1.18
Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J Virol (1988) 1.15
Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function. J Virol (1995) 1.02
Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells. J Virol (1986) 0.98
Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells. Int J Cancer (1979) 0.97
Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells. Cancer Res (1987) 0.93
Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Cancer Res (1986) 0.89
Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch Virol (1984) 0.87
Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus. J Virol (1978) 0.85
Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle. J Gen Virol (1991) 0.82
Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. J Gen Virol (1982) 0.81
Epstein-Barr virus activators, mutagens and volatile nitrosamines in preserved food samples from high-risk areas for nasopharyngeal carcinoma. IARC Sci Publ (1991) 0.78
Methanol fixation permits flow cytometric analysis of immunofluorescent stained intracellular antigens. J Immunol Methods (1987) 0.78
Effect of protein kinase C inhibitors with different action mechanisms on Epstein-Barr virus replication. Intervirology (1992) 0.77
Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus. Acta Virol (1985) 0.77
Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line. Hematol Oncol (1985) 0.77
THE INFECTION OF SUB-CELLULAR ESCHERICHIA COLI, STRAIN B, WITH A DNA PREPARATION FROM T2 BACTERIOPHAGE. Proc Natl Acad Sci U S A (1957) 6.36
Recovery of DNA segments from agarose gels. Anal Biochem (1980) 5.66
Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A (1967) 5.55
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A (1999) 4.35
Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature (1996) 3.92
The P22 bacteriophage DNA molecule. I. The mature form. J Mol Biol (1968) 3.63
Molecular cloning of DNA fragments produced by restriction endonucleases Sa1I and BamI. Proc Natl Acad Sci U S A (1976) 3.32
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res (1997) 3.18
Visualization of bacterial genes in action. Science (1970) 3.18
Isolation of open-circular DNA molecules by retention in agar gels. J Mol Biol (1970) 3.07
Recombination of DNA molecules. Prog Nucleic Acid Res Mol Biol (1966) 3.06
Palindromes in chromosomes. J Mol Biol (1974) 3.02
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02
Terminal repetition in permuted T2 bacteriophage DNA molecules. J Mol Biol (1967) 2.99
The genetic organization of chromosomes. Annu Rev Genet (1971) 2.83
Terminal repetition in non-permuted T3 and T7 bacteriophage DNA molecules. J Mol Biol (1967) 2.61
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A (1998) 2.55
A miniature microelectrode array to monitor the bioelectric activity of cultured cells. Exp Cell Res (1972) 2.47
Cyclization of eucaryotic deoxyribonucleic acid fragments. J Mol Biol (1970) 2.43
Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology (2003) 2.28
Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages. Mol Microbiol (1995) 2.25
RIGHT PARADUODENAL HERNIA. Ann Surg (1941) 2.18
NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim (1996) 2.09
An antifungal polyacetylene compound from phytophthora-infected safflower. Phytopathology (1970) 2.02
An intermediate in the replication of bacteriophage T7 DNA molecules. J Mol Biol (1969) 2.02
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol (1999) 2.00
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst (1995) 1.91
Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol (1999) 1.89
A new method for mapping nucleic acid sequence homology by electron microscopy. Nucleic Acids Res (1975) 1.87
The cohering telomeres of Oxytricha. Nucleic Acids Res (1987) 1.87
PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses (2003) 1.85
Risk of pulmonary complications after elective abdominal surgery. Chest (1996) 1.84
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol (1995) 1.81
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet (1999) 1.76
The P22 bacteriophage DNA molecule. II. Circular intracellular forms. J Mol Biol (1968) 1.72
Length polymorphisms, restriction site variation, and maternal inheritance of mitochondrial DNA of Drosophila melanogaster. Plasmid (1980) 1.69
Interplay between mycoplasmas and host target cells. Microb Pathog (1995) 1.67
Hydroxyapatite chromatography of short double-helical DNA. Biochim Biophys Acta (1973) 1.66
Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol (1998) 1.65
Simian virus 40 carrying an Escherichia coli suppressor gene. J Mol Biol (1977) 1.65
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. J Clin Oncol (2005) 1.63
Riboflavin uptake by human-derived colonic epithelial NCM460 cells. Am J Physiol Cell Physiol (2000) 1.59
p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res (1993) 1.59
Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol Aging (1998) 1.56
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res (1997) 1.54
The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res (1993) 1.54
Hydrodynamic shear breakage of DNA may produce single-chained terminals. Biochim Biophys Acta (1972) 1.53
Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics (1985) 1.51
Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer (1994) 1.51
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst (2000) 1.50
Regular arrangement of restriction sites in Drosophila DNA. Cell (1975) 1.49
The arrangement of information in DNA molecules. J Gen Physiol (1966) 1.48
The intracellular forms of T7 and P22 DNA molecules. Cold Spring Harb Symp Quant Biol (1968) 1.48
Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J Biol Chem (1994) 1.47
Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis. Science (1977) 1.47
Transplant therapy: recovery of function after spinal cord injury. J Neurotrauma (1997) 1.46
A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL+ adherent tumor cells. J Immunol Methods (1998) 1.46
Some special structural features of intracellular bacteriophage T7 concatemers. J Mol Biol (1972) 1.44
Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings. Pediatrics (1985) 1.42
Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet (1999) 1.42
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol (1996) 1.41
Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics (2011) 1.40
The separation of DNA segments attached to proteins. Anal Biochem (1979) 1.40
Compositional differences between meteorites and near-Earth asteroids. Nature (2008) 1.39
Generation of infectious retrovirus aerosol through medical laser irradiation. Lasers Surg Med (1998) 1.39
Nuclear RNA transcripts from Drosophila melanogaster ribosomal RNA genes containing introns. Nucleic Acids Res (1980) 1.38
Ribosomal association of the yeast SAL4 (SUP45) gene product: implications for its role in translation fidelity and termination. Mol Microbiol (1992) 1.37
Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med (1995) 1.34
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene (2009) 1.32
Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg (1985) 1.30
Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem (2001) 1.29
The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J (1998) 1.26
Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer. Clin Cancer Res (1996) 1.26
Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol (2007) 1.24
Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients. Vet Parasitol (2000) 1.23
Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clin Cancer Res (2001) 1.22
The efficacy of selamectin in the treatment of naturally acquired aural infestations of otodectes cynotis on dogs and cats. Vet Parasitol (2000) 1.22
Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat (1999) 1.21
Phase I and pharmacokinetic trial of weekly CPT-11. J Clin Oncol (1993) 1.20
Local destabilization of DNA during transcription. J Mol Biol (1972) 1.20
cDNA expression arrays reveal incomplete reversal of age-related changes in gene expression by calorie restriction. Mech Ageing Dev (2000) 1.20
The rule of the ring. J Cell Physiol (1967) 1.19
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol Cell Biol (1997) 1.17
Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro. J Natl Cancer Inst (1992) 1.16
The organization of Drosophila melanogaster histone genes. Cold Spring Harb Symp Quant Biol (1981) 1.15
L-Histidine tetrafluoroborate: a solution-grown semiorganic crystal for nonlinear frequency conversion. Opt Lett (1995) 1.13
A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. Blood (1998) 1.13
Preparative nonlytic separation of Lyt2+ and Lyt2- T lymphocytes, functional analyses of the separated cells and demonstration of synergy in graft-vs.-host reaction of Lyt2+ and Lyt2- cells. Eur J Immunol (1981) 1.13
Differential binding of fluorescein-labeled lectins to mouse thymocytes: subsets revealed by flow microfluorometry. J Immunol (1980) 1.12
Human colon cells: culture and in vitro transformation. Science (1984) 1.12
Rotating-wall vessel coculture of small intestine as a prelude to tissue modeling: aspects of simulated microgravity. Proc Soc Exp Biol Med (1993) 1.11
AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene (2001) 1.10
Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst (1996) 1.10
The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol (1992) 1.10
Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2. J Exp Med (1998) 1.10
Analysis of DNA bearing single-chained terminals by BNC chromatography. Anal Biochem (1972) 1.10
Fall in human herpesvirus 6 seropositivity with age. Lancet (1988) 1.09
Measure once or twice -- does it really matter? J Natl Cancer Inst (1999) 1.09